Finally for the first afternoon session is Dr Michael Pienaar, who is speaking on 'Machine Learning to Tailor Management Strategies'. #VTA23
Central to this are the definitions of Artificial Intelligence, Machine Learning and Deep Learning. #VTA23
Statistics --> Machine Learning --> Soft AI --> Hard AI --> General AI
These exist on several spectra
Human Operator --> Self-operated
Seen rules --> Unseen rules
etc... #VTA23
This talk is breaking my brain a little, but... Some take home points:
The advent of Learning Health Systems - where 'primary' research generates treatment strategies, which generates data, which then generates further research - WITHOUT a further study being done. #VTA23
Pattern Recognition - application in radiology and other forms of imaging (e.g. retinoscopy) to identify earlier markers of disease. #VTA23
The lack of a regulatory framework may become a problem. Bioethical considerations always come up. The fear of the 'Skynet' prevails... #VTA23
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Why do we put tracheostomies in patients though?
The rationale for a trachy in ICU is that there are respiratory mechanical benefit (compare to a tracheal tube and a native airway). There are many patient care benefits - oral care, feeding, etc... #VTA23
There are problems, including the potential for real patient harm. Tracheostomy emergencies are a problem. Complications (Immediate, Early and Late) are encountered in 30% of patients. #VTA23
Next is Donna Hamel, speaking on 'PEEP Titration and Recruitment' #VTA23#critcare#FOAMcc
PEEP is important - it improves oxygenation, and is an essential component of lung protective strategies.
But PEEP also has some problems - it can cause hypotension and increased pulmonary vascular resistance.
So how does one get optimal PEEP? #VTA23
Optimal PEEP has no clear universal definition.
Maybe we should look for appropriate PEEP - a PEEP value that results in adequate oxygenation with the lowest risk of overdistension. #VTA23
Prof Anthony Holley is speaking next on 'Respiratory Support in the Trauma Patient' #VTA23#critcare#FOAMcc
The 'trauma' patient is not a single disease entity, but ultimately a mechanism that is characterised by a shared multitude of pathophysiological patterns (TBI, lung contusion, etc...) and interventions (surgery, transfusion) that lead to some common disease processes. #VTA23
These common disease processes include TRALI, ARDS, TIC and many more.
Of concern, ARDS is not uncommon in trauma patients. #VTA23
Next up are two of the Occupational Therapists from CHBAH - Marche van der Heyden and Tiffany Fairbairn - speaking on 'Sensory Stimulation in Critical Care'. #VTA23#critcare#FOAMcc
Sensory stimulation is emerging in critical care as a modality to re-establish normal functioning. Our senses are our connection to the world. There are 8 (not 5!) senses - auditory, olfactory, gustatory, visual, tactile/touch, vestibular, proprioception and interoception. #VTA23
The lesser known of these - vestibular, proprioception and interoception - all are key in self-soothing...
Interoception is the sense how different parts of our 'deep' body are feeling. There are a few activities that include all 8 senses - for example eating. #VTA23
Midmorning #VTA23 session starting - lots of short talks so expect quick changes in topic! #critcare#FOAMcc
Michael Gentile - Is PARDIE Changing Our View of Paediatric ARDS? #VTA23#FOAMcc#critcare
PARDIE stands for Pediatric ARDS Incidence and Epidemiology study. This study is one of the results of the PALISI Conference Group. doi.org/10.1016/S2213-… #VTA23
Last up for the morning session is John Davies, who is talking about 'Mechanical Ventilation during ECMO: all, some or none'. #VTA23#FOAMcc#critcare
Essential to remember the components of lung protective ventilation - tidal volume, plateau pressure, respiratory rate, PEEP, FiO2. #VTA23
Do the rules of LPV change when the patient is on ECMO.
There is little doubt that (in appropriately selected patients) ECMO has a mortality benefit. Have a look at the CESAR and EOLIA trials: doi.org/10.1016/S0140-… doi.org/10.1056/NEJMoa… #VTA23